Aims We aimed to study the clinicopathological and molecular features of high‐grade non‐
anaplastic thyroid carcinomas (HGTCs), a carcinoma with a prognosis intermediate between …

Differentiated high-grade thyroid carcinoma (DHGTC) is a new entity in the 2022 WHO
classification. We aimed to investigate the incidence and clinicopathological features of …

Abstract In the upcoming World Health Organization fifth edition classification of endocrine
tumors, there were several major changes related to high grade follicular-derived thyroid …

Poorly differentiated thyroid carcinoma - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Anaplastic (ATC) and poorly differentiated thyroid cancer (PDTC) are very aggressive
cancers whose histological diagnosis is not always straightforward. Clinical, pathological …

Aims To characterise the mutational profiles of poorly differentiated thyroid carcinoma
(PDTC) and anaplastic thyroid carcinoma (ATC) and to identify markers with potential …

Background: Poorly differentiated thyroid cancer (PDTC) is a rare but clinically highly
significant entity because it accounts for most fatalities from non-anaplastic follicular cell …

Background: Distant metastases (DM) are a rare occurrence in well-differentiated thyroid
carcinoma. The aim of this study was to analyze the clinical, pathologic, and molecular …

Background Poorly differentiated thyroid carcinoma (PDTC) and anaplastic
(undifferentiated) thyroid carcinoma (ATC) comprise a small subset of thyroid tumors that are …

Background: Anaplastic thyroid carcinoma (ATC) is nearly always fatal. Large studies on
ATC are exceedingly rare. We aimed to study the clinical, genotypic, and histologic …